Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey

Journal of the American Academy of Dermatology

Volumn 76, Issue 2, 2017, Pages 281-285

  Totri, Christine R ^a   Eichenfield, Lawrence F ^b   Logan, Kirsty ^c   Proudfoot, Laura ^c   Schmitt, Jochen ^d   Lara Corrales, Irene ^e   Sugarman, Jeffrey ^f   Tom, Wynnis ^b   Siegfried, Elaine ^g   Cordoro, Kelly ^f   Paller, Amy S ^h   Flohr, Carsten ^c  

^a SUNY Downstate Medical Center   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

atopic dermatitis; azathioprine; cyclosporine; methotrexate; mycophenolate mofetil; oral antimicrobials; oral steroids

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID;

ADULT; ARTICLE; ATOPIC DERMATITIS; CANADA; CHILDHOOD DISEASE; CLINICAL PRACTICE; DERMATOLOGIST; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG SAFETY; FEMALE; HEALTH CARE SURVEY; HUMAN; MALE; MIDDLE AGED; PRESCRIPTION; PRIORITY JOURNAL; SYSTEMIC THERAPY; UNITED STATES; CHILD; DERMATITIS, ATOPIC; DERMATOLOGY; PEDIATRICS; SEVERITY OF ILLNESS INDEX; STANDARDS;

ADULT; AZATHIOPRINE; CANADA; CHILD; CYCLOSPORINE; DERMATITIS, ATOPIC; DERMATOLOGY; DRUG PRESCRIPTIONS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; PEDIATRICS; PRACTICE PATTERNS, PHYSICIANS'; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 85006797322     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2016.09.021     Document Type: Article

References (7)

1. Spergel, J.M., Paller, A.S., Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112:6 Suppl (2003), S118–S127.
2. Proudfoot, L.E., Powell, A.M., Ayis, S., et al. The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey. Br J Dermatol 169:4 (2013), 901–909.
3. Schram, M.E., Roekevisch, E., Leeflang, M.M., Bos, J.D., Schmitt, J., Spuls, P.I., A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 128:2 (2011), 353–359.
4. El-Khalawany, M.A., Hassan, H., Shaaban, D., Ghonaim, N., Eassa, B., Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt. Eur J Pediatr 172:3 (2013), 351–356.
5. Haeck, I.M., Knol, M.J., Ten Berge, O., van Velsen, S.G., de Bruin-Weller, M.S., Bruijnzeel-Koomen, C.A., Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 64:6 (2011), 1074–1084.
6. Tsakok, T., Flohr, C., Methotrexate vs ciclosporin in the treatment of severe atopic dermatitis in children: a critical appraisal. Br J Dermatol 170:3 (2014), 496–498 discussion 498-499.
7. Slater, N.A., Morrell, D.S., Systemic therapy of childhood atopic dermatitis. Clin Dermatol 33:3 (2015), 289–299.